154 related articles for article (PubMed ID: 8991059)
1. Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice.
Douglas GR; Jiao J; Gingerich JD; Soper LM; Gossen JA
Environ Mol Mutagen; 1996; 28(4):317-24. PubMed ID: 8991059
[TBL] [Abstract][Full Text] [Related]
2. DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents.
Mientjes EJ; Luiten-Schuite A; van der Wolf E; Borsboom Y; Bergmans A; Berends F; Lohman PH; Baan RA; van Delft JH
Environ Mol Mutagen; 1998; 31(1):18-31. PubMed ID: 9464312
[TBL] [Abstract][Full Text] [Related]
3. Organ variation in the mutagenicity of ethylnitrosourea in Muta mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. The Collaborative Study Group for the Transgenic Mouse Mutation Assay Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan.
Environ Mol Mutagen; 1996; 28(4):363-75. PubMed ID: 8991065
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the Big Blue rat-2 embryo cell line.
Zimmer DM; Zhang XB; Harbach PR; Mayo JK; Aaron CS
Environ Mol Mutagen; 1996; 28(4):325-33. PubMed ID: 8991060
[TBL] [Abstract][Full Text] [Related]
5. Time course of cII gene mutant manifestation in the liver, spleen, and bone marrow of N-ethyl-N-nitrosourea-treated Big Blue transgenic mice.
Wang J; Liu X; Heflich RH; Chen T
Toxicol Sci; 2004 Nov; 82(1):124-8. PubMed ID: 15282403
[TBL] [Abstract][Full Text] [Related]
6. A test for neutrality of mutations of the lacZ transgene.
Cosentino L; Heddle JA
Environ Mol Mutagen; 1996; 28(4):313-6. PubMed ID: 8991058
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
[TBL] [Abstract][Full Text] [Related]
8. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse).
Suzuki T; Hayashi M; Wang X; Yamamoto K; Ono T; Myhr BC; Sofuni T
Mutat Res; 1997 Dec; 395(1):75-82. PubMed ID: 9465915
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the molecular characteristics of lacZ transgenic mouse mutations detected by visual and positive selection.
Jiao J; Douglas GR; Gingerich JD; Soper LM
Mutat Res; 1996 Nov; 372(1):141-5. PubMed ID: 9003541
[TBL] [Abstract][Full Text] [Related]
12. A study of ENU-induced mutagenesis in the mouse using the restriction site mutation (RSM) assay.
Jenkins GJ; Takahashi N; Parry JM
Teratog Carcinog Mutagen; 1999; 19(4):281-92. PubMed ID: 10406892
[TBL] [Abstract][Full Text] [Related]
13. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections.
Nohmi T; Katoh M; Suzuki H; Matsui M; Yamada M; Watanabe M; Suzuki M; Horiya N; Ueda O; Shibuya T; Ikeda H; Sofuni T
Environ Mol Mutagen; 1996; 28(4):465-70. PubMed ID: 8991079
[TBL] [Abstract][Full Text] [Related]
14. Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.
Recio L; Bond JA; Pluta LJ; Sisk SC
IARC Sci Publ; 1993; (127):235-43. PubMed ID: 8070869
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
16. A lacZ transgenic mouse assay for the detection of mutations in follicular granulosa cells.
Yauk CL; Gingerich JD; Soper L; MacMahon A; Foster WG; Douglas GR
Mutat Res; 2005 Oct; 578(1-2):117-23. PubMed ID: 16039675
[TBL] [Abstract][Full Text] [Related]
17. Sequencing analysis of mutations induced by N-ethyl-N-nitrosourea at different sampling times in mouse bone marrow.
Wang J; Chen T
J Appl Toxicol; 2010 Mar; 30(2):133-41. PubMed ID: 19764070
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutation in the mammary gland: influence of time and estrus.
Sun B; Shima N; Heddle JA
Mutat Res; 1999 Jun; 427(1):11-9. PubMed ID: 10354497
[TBL] [Abstract][Full Text] [Related]
19. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
[TBL] [Abstract][Full Text] [Related]
20. Frequency and spectrum of lacI mutations in the liver of Big Blue mice following the administration of genotoxic carcinogens singly and in series.
Delker DA; Geter DR; Kleinert KM; Gollapudi BB
Int J Toxicol; 2008; 27(1):35-42. PubMed ID: 18293211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
